Related Experiment Video
Updated: Aug 16, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Pharmacoeconomics of schizophrenia in the 21st century
1Division of Medical Assistance, Commonwealth of Massachusetts, Boston, USA. ahanson@nt.dma.state.ma.US
Abstract:
During the next century-if not before-a variety of issues associated with mental health care in the United States need to be addressed and resolved nationwide, including securing full parity for patients with psychiatric disorders, improving the overall medical health of psychiatric patients, establishing the effectiveness as well as the efficacy of new drugs and educating health care providers about new drugs and new uses for older drugs, and using all costs to evaluate new therapeutic strategies or medications. The following discussion covers some of the major findings from studies conducted in the Commonwealth of Massachusetts, touches on some of the areas mentioned above, and is intended to serve as a springboard for exchanges among professionals in the health care community who care for psychiatric patients.
More Related Videos
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychosis: Goals of Pharmacotherapy
Schizophrenia
Psychological and Sociocultural Causes of Schizophrenia
Drug Therapy
Antianxiety Medications

